Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 37

1.

Eicosapentaenoic Acid Reduces Fecal Levels of Calprotectin and Prevents Relapse in Patients With Ulcerative Colitis.

Scaioli E, Sartini A, Bellanova M, Campieri M, Festi D, Bazzoli F, Belluzzi A.

Clin Gastroenterol Hepatol. 2018 Aug;16(8):1268-1275.e2. doi: 10.1016/j.cgh.2018.01.036. Epub 2018 Jan 31.

PMID:
29391271
2.

The Imbalance between n-6/n-3 Polyunsaturated Fatty Acids and Inflammatory Bowel Disease: A Comprehensive Review and Future Therapeutic Perspectives.

Scaioli E, Liverani E, Belluzzi A.

Int J Mol Sci. 2017 Dec 5;18(12). pii: E2619. doi: 10.3390/ijms18122619. Review.

3.

Short-term treatment with eicosapentaenoic acid improves inflammation and affects colonic differentiation markers and microbiota in patients with ulcerative colitis.

Prossomariti A, Scaioli E, Piazzi G, Fazio C, Bellanova M, Biagi E, Candela M, Brigidi P, Consolandi C, Balbi T, Chieco P, Munarini A, Pariali M, Minguzzi M, Bazzoli F, Belluzzi A, Ricciardiello L.

Sci Rep. 2017 Aug 7;7(1):7458. doi: 10.1038/s41598-017-07992-1.

4.

A liquid chromatography-tandem mass spectrometry method to measure fatty acids in biological samples.

Volpato M, Spencer JA, Race AD, Munarini A, Belluzzi A, Cockbain AJ, Hull MA, Loadman PM.

J Chromatogr B Analyt Technol Biomed Life Sci. 2017 Jun 15;1055-1056:125-134. doi: 10.1016/j.jchromb.2017.04.030. Epub 2017 Apr 24.

5.

Sulfasalazine in Prevention of Pouchitis After Proctocolectomy with Ileal Pouch-Anal Anastomosis for Ulcerative Colitis.

Scaioli E, Sartini A, Liverani E, Digby RJ, Ugolini G, Rosati G, Poggioli G, Festi D, Bazzoli F, Belluzzi A.

Dig Dis Sci. 2017 Apr;62(4):1016-1024. doi: 10.1007/s10620-017-4454-9. Epub 2017 Jan 21.

PMID:
28110377
6.

Is Early Endoscopy-Based Therapy the Best Strategy to Prevent All Crohn's Disease Postoperative Recurrence?

Sartini A, Scaioli E, Belluzzi A.

Gastroenterology. 2016 Nov;151(5):1040-1041. doi: 10.1053/j.gastro.2016.08.058. Epub 2016 Oct 1. No abstract available.

PMID:
27702633
7.

Different Cutoff Levels of Fecal Calprotectin to Predict Clinical Relapse in Ulcerative Colitis.

Scaioli E, Digby RJ, Belluzzi A.

Inflamm Bowel Dis. 2016 Jul;22(7):E26. doi: 10.1097/MIB.0000000000000839. No abstract available.

PMID:
27271496
8.

MRI Patterns in a Case of 6-Thioguanine-Related Hepatic Sinusoidal Obstruction Syndrome.

Marasco G, Scaioli E, Renzulli M, Colecchia A, Golfieri R, Festi D, Bazzoli F, Digby RJ, Belluzzi A.

Am J Gastroenterol. 2016 Jun;111(6):767. doi: 10.1038/ajg.2016.210. No abstract available.

PMID:
27249976
9.

Inflammation increases NOTCH1 activity via MMP9 and is counteracted by Eicosapentaenoic Acid-free fatty acid in colon cancer cells.

Fazio C, Piazzi G, Vitaglione P, Fogliano V, Munarini A, Prossomariti A, Milazzo M, D'Angelo L, Napolitano M, Chieco P, Belluzzi A, Bazzoli F, Ricciardiello L.

Sci Rep. 2016 Feb 11;6:20670. doi: 10.1038/srep20670.

10.

How to predict clinical relapse in inflammatory bowel disease patients.

Liverani E, Scaioli E, Digby RJ, Bellanova M, Belluzzi A.

World J Gastroenterol. 2016 Jan 21;22(3):1017-33. doi: 10.3748/wjg.v22.i3.1017. Review.

11.

A proposed staging system and stage-specific interventions for familial adenomatous polyposis.

Lynch PM, Morris JS, Wen S, Advani SM, Ross W, Chang GJ, Rodriguez-Bigas M, Raju GS, Ricciardiello L, Iwama T, Rossi BM, Pellise M, Stoffel E, Wise PE, Bertario L, Saunders B, Burt R, Belluzzi A, Ahnen D, Matsubara N, B├╝low S, Jespersen N, Clark SK, Erdman SH, Markowitz AJ, Bernstein I, De Haas N, Syngal S, Moeslein G.

Gastrointest Endosc. 2016 Jul;84(1):115-125.e4. doi: 10.1016/j.gie.2015.12.029. Epub 2016 Jan 6.

12.

The Pharmacokinetic Profile of a New Gastroresistant Capsule Preparation of Eicosapentaenoic Acid as the Free Fatty Acid.

Scaioli E, Cardamone C, Liverani E, Munarini A, Hull MA, Belluzzi A.

Biomed Res Int. 2015;2015:360825. doi: 10.1155/2015/360825. Epub 2015 Aug 3.

13.

Clinical application of faecal calprotectin in ulcerative colitis patients.

Scaioli E, Scagliarini M, Cardamone C, Liverani E, Ugolini G, Festi D, Bazzoli F, Belluzzi A.

Eur J Gastroenterol Hepatol. 2015 Dec;27(12):1418-24. doi: 10.1097/MEG.0000000000000461.

PMID:
26308711
14.

Can fecal calprotectin better stratify Crohn's disease activity index?

Scaioli E, Cardamone C, Scagliarini M, Zagari RM, Bazzoli F, Belluzzi A.

Ann Gastroenterol. 2015 Apr-Jun;28(2):247-252.

15.

Acute Fitz-Hugh-Curtis syndrome in a man due to gonococcal infection.

Nardini P, Compri M, Marangoni A, D'Antuono A, Bellavista S, Calvanese C, Belluzzi A, Bazzoli F, Montagnani M.

J Emerg Med. 2015 Mar;48(3):e59-62. doi: 10.1016/j.jemermed.2014.04.043. Epub 2014 Dec 12.

PMID:
25511465
16.

Mycobacterium avium subspecies paratuberculosis in the etiology of Crohn's disease, cause or epiphenomenon?

Liverani E, Scaioli E, Cardamone C, Dal Monte P, Belluzzi A.

World J Gastroenterol. 2014 Sep 28;20(36):13060-70. doi: 10.3748/wjg.v20.i36.13060. Review.

17.

A combination of eicosapentaenoic acid-free fatty acid, epigallocatechin-3-gallate and proanthocyanidins has a strong effect on mTOR signaling in colorectal cancer cells.

D'Angelo L, Piazzi G, Pacilli A, Prossomariti A, Fazio C, Montanaro L, Graziani G, Fogliano V, Munarini A, Bianchi F, Belluzzi A, Bazzoli F, Ricciardiello L.

Carcinogenesis. 2014 Oct;35(10):2314-20. doi: 10.1093/carcin/bgu173. Epub 2014 Aug 14.

PMID:
25123131
18.

Eicosapentaenoic acid free fatty acid prevents and suppresses colonic neoplasia in colitis-associated colorectal cancer acting on Notch signaling and gut microbiota.

Piazzi G, D'Argenio G, Prossomariti A, Lembo V, Mazzone G, Candela M, Biagi E, Brigidi P, Vitaglione P, Fogliano V, D'Angelo L, Fazio C, Munarini A, Belluzzi A, Ceccarelli C, Chieco P, Balbi T, Loadman PM, Hull MA, Romano M, Bazzoli F, Ricciardiello L.

Int J Cancer. 2014 Nov 1;135(9):2004-13. doi: 10.1002/ijc.28853. Epub 2014 Mar 28.

19.

Anticolorectal cancer activity of the omega-3 polyunsaturated fatty acid eicosapentaenoic acid.

Cockbain AJ, Volpato M, Race AD, Munarini A, Fazio C, Belluzzi A, Loadman PM, Toogood GJ, Hull MA.

Gut. 2014 Nov;63(11):1760-8. doi: 10.1136/gutjnl-2013-306445. Epub 2014 Jan 27.

PMID:
24470281
20.

n-3 fatty acids in patients with cardiac risk factors.

Scaioli E, Belluzzi A.

N Engl J Med. 2013 Aug 22;369(8):781. doi: 10.1056/NEJMc1308780. No abstract available.

PMID:
23964945

Supplemental Content

Loading ...
Support Center